TipRanks
Go Ultimate55% OFF

PharmaNutra SpA (PHN) Stock Forecast & Price Target

See the Price Targets and Ratings of:

PHN Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to PharmaNutra SpA in the past 3 months

PHN Stock 12 Month Forecast

EUR 97.00▲(35.10% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for PharmaNutra SpA in the last 3 months. The average price target is EUR 97.00 with a high forecast of EUR 102.00 and a low forecast of EUR 92.00. The average price target represents a 35.10% change from the last price of EUR 71.80.
Highest Price TargetEUR 102.00Average Price TargetEUR 97.00Lowest Price TargetEUR 92.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for IT:PHN
Price TargetFollowArticle
IntermonteEUR 98→EUR 102buy42.06%UpsideReiterated09/14/26
TP ICAP MIDCAPEUR 92buy28.13%UpsideReiterated09/14/26
Berenberg BankEUR 85→EUR 93buy29.53%UpsideReiterated05/12/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
REPLReplimune Group
IMUXImmunic
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering PharmaNutra SpA

3 Months
Success Rate9/16 ratings generated profit
56%
Average Return
+4.99%

Copying Giorgio Tavolini's trades and holding each position for 3 Months would result in 56.25% of your transactions generating a profit, with an average return of +4.99% per trade.

1 Year
Corentin Marty
Corentin MartyTP ICAP MIDCAP
Success Rate8/11 ratings generated profit
73%
Average Return
+27.77%

Copying Corentin Marty's trades and holding each position for 1 Year would result in 72.73% of your transactions generating a profit, with an average return of +27.77% per trade.

2 Years
Corentin Marty
Corentin MartyTP ICAP MIDCAP
Success Rate10/11 ratings generated profit
91%
Average Return
+41.82%

Copying Corentin Marty's trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +41.82% per trade.

PHN Analyst Recommendation Trends

02468Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for PHN
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy22022
Hold00000
Sell00000
Strong Sell00000
total22022

In the current month, PHN has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PHN average Analyst price target in the past 3 months is 97.00.

PHN Financial Forecast

EUR -1EUR -0.5EUR 0EUR 0.5EUR 1Q4 2025Q2 2026Q3 2026
HighEUR 0.83
ConsensusEUR 0.83
LowEUR 0.83

PHN Earnings Forecast

Next quarter’s earnings estimate for PHN is EUR 0.83 with a range of EUR 0.83 to EUR 0.83. The previous quarter’s EPS was EUR 0.67. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

EUR 32.7MEUR 34.6MEUR 36.6MEUR 38.5MEUR 40.4MQ4 2025Q2 2026Q3 2026
HighEUR 40.4M
ConsensusEUR 40.4M
LowEUR 40.4M

PHN Sales Forecast

Next quarter’s sales forecast for PHN is EUR 40.40M with a range of EUR 40.40M to EUR 40.40M. The previous quarter’s sales results were EUR 40.25M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

PHN Stock Forecast FAQ

What is IT:PHN’s average 12-month price target, according to analysts?
Based on analyst ratings, PharmaNutra SpA’s 12-month average price target is €97.00.
What is IT:PHN’s upside potential, based on the analysts’ average price target?
PharmaNutra SpA has 35.10% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PharmaNutra SpA a Buy, Sell or Hold?
PharmaNutra SpA has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is PharmaNutra SpA’s share price target?
The average share price target for PharmaNutra SpA is €97.00. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €102.00, and the lowest forecast is €92.00. The average share price target represents a 35.10% increase from the current price of €71.8.
What do analysts say about PharmaNutra SpA?
PharmaNutra SpA’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of PharmaNutra SpA?
To buy shares of IT:PHN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.